Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142387 |
| CAS No | 2492451-27-9 |
| Mol.F. | C6H13N5O3 |
| Mol.Wt. | 203.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142388 |
| CAS No | NA |
| Mol.F. | C15H20N4O3S3 |
| Mol.Wt. | 400.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142389 |
| CAS No | NA |
| Mol.F. | C13H19N3O4S |
| Mol.Wt. | 313.37 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142390 |
| CAS No | NA |
| Mol.F. | C12H17N3O4S |
| Mol.Wt. | 299.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142391 |
| CAS No | NA |
| Mol.F. | C15H23N3O4S |
| Mol.Wt. | 341.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142392 |
| CAS No | NA |
| Mol.F. | C15H24N4O3S |
| Mol.Wt. | 340.44 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142393 |
| CAS No | NA |
| Mol.F. | C14H21N3O4S |
| Mol.Wt. | 327.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142394 |
| CAS No | NA |
| Mol.F. | C13H19N3O4S |
| Mol.Wt. | 313.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142395 |
| CAS No | NA |
| Mol.F. | C12H17N3O4S |
| Mol.Wt. | 299.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142396 |
| CAS No | NA |
| Mol.F. | C20H17ClF2N6O4 |
| Mol.Wt. | 478.84 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142397 |
| CAS No | NA |
| Mol.F. | C16H13ClN2O3 |
| Mol.Wt. | 316.74 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142398 |
| CAS No | NA |
| Mol.F. | C16H13ClN2O6S |
| Mol.Wt. | 396.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142399 |
| CAS No | NA |
| Mol.F. | C16H9ClN2O2 |
| Mol.Wt. | 296.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142400 |
| CAS No | NA |
| Mol.F. | C16H14N2O2 |
| Mol.Wt. | 266.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142401 |
| CAS No | NA |
| Mol.F. | C16H15ClN2O2 |
| Mol.Wt. | 302.76 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142402 |
| CAS No | NA |
| Mol.F. | C16H14N2O2 |
| Mol.Wt. | 266.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |